Prevention of preterm birth and subsequent newborn immaturity is a primary goal of obstetrical care worldwide. Accumulated evidence shows that 1) as many as 25-50% of preterm births are caused by common genital tract infections and subsequent maternal/fetal inflammatory responses; 2) microbial and maternal host factors (phospholipases, proteases, etc.) play roles in preterm labor and preterm premature rupture of membranes (pPROM); 3) integrated aspects of maternal and fetal host responses (inflammation, altered immune adaptations, endocrine and paracrine mechanisms) play increasingly understood roles in premature activation of parturition; and 4) identification and systemic treatment of common genitourinary infections, most importantly bacterial vaginosis (BV), reduce the risks of preterm delivery and PROM. Infect.
".Infection in the female reproductive tract (especially in the cewix) can cause premature rupture of membranes and induce premature labor.... This process is responsible for many preventable infant deaths. 1,, estational age at birth and birth weight are the most important biologic determinants worldwide of an individual child's chances of survival and healthy growth, e Immediate sequelae of biologic immaturity at birth include respiratory distress, intraventricular hemorrhage, leukomalacia, necrotizing enterocolitis, prolonged hospitalization, and death. 3, 4 Among survivors, life-long complications can include cerebral palsy, cognitive impairment, blindness, and deafness. 3 preterm birth by induction of matrix metalloproteases, which in turn enhance cervical ripening and weakening of the amnionchorion. 37 Experiments performed with human fetal membranes show that substances produced by both microbes and host inflammatory cells have been shown to mediate prostaglandin release and membrane weakening in vitro. 21, 22 Importantly, addition of appropriate antimicrobials including erythromycin and metronidazole during in vitro experiments of fetal membrane tensile strength prevents bacteria-induced fetal membrane weakening. 28, 38 Choice of antibiotics to treat infectious agents in both in vitro and in vivo and clinical investigations regarding preterm birth is crucial: agents such as clindamycin, erythromycin, aminoglycosides, and metronidazole tend to shut down bacterial virulence factor production. Conversely Future studies will focus on more accurately defining women and babies at risk, elucidating pathogenic interactions between microbes and both maternal and fetal hosts, and refining diagnostic and treatment strategies so as to provide maximum benefits while incurring minimal adverse effects and costs.
Medical care providers now have new opportunities and obligations to prevent as many infectionmediated births as possible by identifying and treating prevalent reproductive tract infections in their patients. We wager that optimal approaches will be shown to include identification and treatment of susceptible women prior to pregnancy, as part of preconceptual counseling and care.
